×
ADVERTISEMENT

OTC

FDA Warns of Infection Risk From OTC Eye Drops

The FDA recommended that manufacturers recall more than 20 eye drop products sold over the counter in retail ...

OCTOBER 31, 2023

California Governor Vetoes Bill Requiring Insurance to Cover Low-Cost Naloxone

A bill that would require California insurers to cover the cost of OTC naloxone was vetoed by the state’s ...

OCTOBER 31, 2023

FDA Approves OTC Version of Opioid Overdose Reversal Agent

The FDA approved the OTC version of naloxone nasal spray to rapidly reverse the effects of opioid overdose.

APRIL 3, 2023

Load more